Shareable Research Card

PMCB - PharmaCyte Biotech, Inc. Operating Margin

This metric view shows PMCB - PharmaCyte Biotech, Inc. operating margin history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q4 2013
Latest reported value
396584%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Open stable link Open company facts

Financial Metric Page

PharmaCyte Biotech, Inc.: Operating Margin

Latest period: Q4 2013. Period end: 31 Jan 2014. Units: %. Frequency: quarterly and annual.

The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.

What This Metric Tells You

  • Shows the reported level of operating margin over 30 Apr 2012 - 31 Jan 2014.
  • Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
  • Built from 10 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

PharmaCyte Biotech, Inc. appears at rank #3 in the latest comparison sample.

Rank Company Latest value Reported period Next step
1 Global Warming Solutions, Inc. (["gwso"]) 99905400% Quarter - 30 Sep 2022 Open Global Warming Solutions, Inc. Operating Margin
2 NAMI Corp. ([]) 1080289% Quarter - 31 Mar 2021 Open NAMI Corp. Operating Margin
3 PharmaCyte Biotech, Inc. (["pmcb"]) 396584% Quarter - 31 Jan 2014 Open PharmaCyte Biotech, Inc. Operating Margin
4 ALR Technologies SG Ltd. (["alrtf"]) 180380% Year - 31 Dec 2022 Open ALR Technologies SG Ltd. Operating Margin
5 MUSTANG BIO, INC. (["mbio"]) 83624% Quarter - 30 Sep 2019 Open MUSTANG BIO, INC. Operating Margin
6 DOMINION ENERGY SOUTH CAROLINA, INC. ([]) 63100% Quarter - 31 Dec 2020 Open DOMINION ENERGY SOUTH CAROLINA, INC. Operating Margin

Metric Details

Metric
Operating Margin (OperatingMargin)
Taxonomy
ratio
Units tracked
%
Frequency coverage
quarterly and annual
History range
30 Apr 2012 - 31 Jan 2014
Facts on this page
10
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

PharmaCyte Biotech, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2013 396584% +405318% 01 Nov 2013 31 Jan 2014
Q3 2013 351400% +355866% 01 Aug 2013 31 Oct 2013
Q2 2013 -46011% -42576% -1239% 01 May 2013 31 Jul 2013
Q1 2013 -13852% -10923% -373% 01 Feb 2013 30 Apr 2013
Q4 2012 -8734% 01 Nov 2012 31 Jan 2013
Q3 2012 -4466% 01 Aug 2012 31 Oct 2012
Q2 2012 -3436% 01 May 2012 31 Jul 2012
Q1 2012 -2929% 01 Feb 2012 30 Apr 2012

PharmaCyte Biotech, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2012 -13852% -10923% -373% 01 May 2012 30 Apr 2013
2011 -2929% 01 May 2011 30 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.

Sponsored